Regulus Therapeutics Total Assets 2011-2020 | RGLS

Regulus Therapeutics total assets from 2011 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
Regulus Therapeutics Annual Total Assets
(Millions of US $)
2019 $42
2018 $28
2017 $78
2016 $101
2015 $141
2014 $171
2013 $123
2012 $104
2011 $43
2010 $0
Regulus Therapeutics Quarterly Total Assets
(Millions of US $)
2020-03-31 $35
2019-12-31 $42
2019-09-30 $21
2019-06-30 $26
2019-03-31 $20
2018-12-31 $28
2018-09-30 $35
2018-06-30 $49
2018-03-31 $62
2017-12-31 $78
2017-09-30 $91
2017-06-30 $62
2017-03-31 $80
2016-12-31 $101
2016-09-30 $116
2016-06-30 $130
2016-03-31 $128
2015-12-31 $141
2015-09-30 $143
2015-06-30 $150
2015-03-31 $165
2014-12-31 $171
2014-09-30 $104
2014-06-30 $114
2014-03-31 $124
2013-12-31 $123
2013-09-30 $131
2013-06-30 $93
2013-03-31 $97
2012-12-31 $104
2012-09-30 $41
2012-06-30 $0
2012-03-31 $0
2011-12-31 $0
2011-09-30 $0
2010-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.018B $0.007B
Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs, called microRNA therapeutics. The Company's products aim to treat or prevent hepatitis C infections, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and metabolic diseases. Regulus Therapeutics Inc. is based in La Jolla, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.751B 37.31
Takeda Pharmaceutical (TAK) Japan $55.142B 9.66
Astellas Pharma (ALPMY) Japan $29.910B 15.16
Eisai (ESALY) Japan $23.461B 20.34
UCB SA (UCBJF) Belgium $23.292B 0.00
Merck (MKGAF) Germany $16.149B 21.18
Grifols, S.A (GRFS) Spain $12.857B 15.98
Neurocrine Biosciences (NBIX) United States $11.883B 54.92
Catalent (CTLT) United States $11.421B 44.15
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.553B 45.47
IPSEN SA ADR (IPSEY) France $7.290B 0.00
Orion OYJ (ORINY) Finland $6.978B 31.27
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.021B 9.64
United Therapeutics (UTHR) United States $5.220B 9.89
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.502B 491.56
Nektar Therapeutics (NKTR) United States $4.297B 0.00
Evotec AG (EVTCY) Germany $4.181B 112.67
Hypermarcas (HYPMY) Brazil $3.762B 11.44
FibroGen (FGEN) United States $3.713B 0.00
ChemoCentryx (CCXI) United States $3.637B 0.00
PTC Therapeutics (PTCT) United States $3.602B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.561B 10.53
Pacira BioSciences (PCRX) United States $2.282B 46.70
Cronos Group (CRON) Canada $2.187B 62.70
Sage Therapeutics (SAGE) United States $2.178B 0.00
Corcept Therapeutics (CORT) United States $1.901B 18.85
Xencor (XNCR) United States $1.857B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.722B 0.00
USANA Health Sciences (USNA) United States $1.708B 17.52
Akebia Therapeutics (AKBA) United States $1.697B 0.00
Indivior (INVVY) United States $1.638B 20.33
Ironwood Pharmaceuticals (IRWD) United States $1.620B 12.40
Zogenix (ZGNX) United States $1.526B 0.00
Esperion Therapeutics (ESPR) United States $1.409B 0.00
Karyopharm Therapeutics (KPTI) United States $1.396B 0.00
Heron Therapeutics (HRTX) United States $1.361B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.359B 14.65
Theravance Biopharma (TBPH) Cayman Islands $1.302B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.250B 0.00
Translate Bio (TBIO) United States $1.103B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.009B 45.05
Tilray (TLRY) Canada $0.961B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.954B 0.00
ImmunoGen (IMGN) United States $0.841B 0.00
Endo (ENDP) Ireland $0.832B 1.29
Molecular Templates (MTEM) United States $0.659B 0.00
VAXART, INC (VXRT) United States $0.658B 0.00
Radius Health (RDUS) United States $0.652B 0.00
Ardelyx (ARDX) United States $0.623B 0.00
Aerie Pharmaceuticals (AERI) United States $0.619B 0.00
Trillium Therapeutics (TRIL) Canada $0.608B 0.00
Collegium Pharmaceutical (COLL) United States $0.586B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.582B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.566B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.519B 12.55
BioSpecifics Technologies Corp (BSTC) United States $0.490B 19.11
Innate Pharma SA (IPHYF) France $0.476B 0.00
Flexion Therapeutics (FLXN) United States $0.475B 0.00
Siga Technologies (SIGA) United States $0.470B 0.00
DURECT (DRRX) United States $0.425B 0.00
TherapeuticsMD (TXMD) United States $0.416B 0.00
Harpoon Therapeutics (HARP) United States $0.414B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.402B 0.00
Ocular Therapeutix (OCUL) United States $0.401B 0.00
Organogenesis Holdings (ORGO) United States $0.380B 0.00
Calithera Biosciences (CALA) United States $0.373B 0.00
MEI Pharma (MEIP) United States $0.364B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.320B 0.00
Concert Pharmaceuticals (CNCE) United States $0.296B 0.00
PROFOUND MEDICL (PROF) Canada $0.292B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.289B 0.00
Lannett Co Inc (LCI) United States $0.268B 5.88
Oasmia Pharmaceutical AB (OASMY) Sweden $0.249B 0.00
Redhill Biopharma (RDHL) Israel $0.248B 0.00
CASI Pharmaceuticals (CASI) United States $0.229B 0.00
Taiwan Liposome (TLC) Taiwan $0.220B 0.00
Jounce Therapeutics (JNCE) United States $0.215B 5.14
KalVista Pharmaceuticals (KALV) United States $0.212B 0.00
OptiNose (OPTN) United States $0.208B 0.00
Rafael Holdings (RFL) United States $0.208B 0.00
IMV INC (IMV) Canada $0.188B 0.00
Nivalis Therapeutics (ALPN) United States $0.181B 0.00
Nature's Sunshine Products (NATR) United States $0.179B 23.59
Altimmune (ALT) United States $0.174B 0.00
Aquestive Therapeutics (AQST) United States $0.154B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.151B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.125B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.124B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
CTI BioPharma (CTIC) United States $0.114B 0.00
Otonomy (OTIC) United States $0.110B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.107B 0.00
Recro Pharma (REPH) United States $0.102B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.101B 0.00
MediWound (MDWD) Israel $0.100B 0.00
Onconova Therapeutics (ONTX) United States $0.099B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.099B 0.00
Xeris Pharmaceuticals (XERS) United States $0.098B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.091B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.091B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
Sundial Growers (SNDL) Canada $0.083B 0.00
Biomerica (BMRA) United States $0.080B 0.00
Heat Biologics (HTBX) United States $0.076B 0.00
Aclaris Therapeutics (ACRS) United States $0.074B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.066B 0.00
Lipocine (LPCN) United States $0.065B 0.00
CV Sciences (CVSI) United States $0.059B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Addex Therapeutics (ADXN) Switzerland $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 30.09
Infinity Pharmaceuticals (INFI) United States $0.050B 0.00
PolarityTE (PTE) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
IsoRay (ISR) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.040B 0.00
Novan (NOVN) United States $0.040B 0.00
GTx (ONCT) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.039B 7.40
Opiant Pharmaceuticals (OPNT) United States $0.039B 83.18
Adamis Pharmaceuticals (ADMP) United States $0.038B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.034B 0.00
AgeX Therapeutics (AGE) United States $0.034B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.033B 0.00
ElectroCore (ECOR) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.027B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.022B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Flex Pharma (SLRX) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Can-Fite Biopharma (CANF) Israel $0.016B 0.00
China SXT Pharmaceuticals (SXTC) China $0.016B 0.00
Shineco (TYHT) China $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 32.71
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Vical (BBI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00